Relating to the manufacture, sale, and distribution of products developed using mRNA material in the prevention or treatment of a communicable disease.
Texas bill establishing state regulatory framework for mRNA-based communicable disease products, potentially duplicating or conflicting with federal pharmaceutical oversight.